A novel signal amplification technique for multiplex immunofluorescence to detect low-expressed biomarkers in the tumor microenvironment

A novel signal amplification technique for multiplex immunofluorescence to detect low-expressed biomarkers in the tumor microenvironment

Application of a Novel Multiplex Imaging-based Immunotherapy Panel and AI-powered Analysis Solution for Predictive Spatial Biomarker Identification on Immunotherapy-treated Melanoma Patients

Application of a Novel Multiplex Imaging-based Immunotherapy Panel and AI-powered Analysis Solution for Predictive Spatial Biomarker Identification on Immunotherapy-treated Melanoma Patients

High-dimensional spatial analysis of murine tumor microenvironment highlights the heterogeneity of primary and metastatic pancreatic cancer immune landscape

High-dimensional spatial analysis of murine tumor microenvironment highlights the heterogeneity of primary and metastatic pancreatic cancer immune landscape

The UBA1–STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade

Spatial predictors of response to immunotherapy inmicrosatellite stable metastatic colorectal cancer

Qualification of Immune Checkpoint Biomarker Antibodies in Glioblastoma with Fully Automated Multiplex Immunofluorescence

Qualification of Immune Checkpoint Biomarker Antibodies in Glioblastoma with Fully Automated Multiplex Immunofluorescence

Profiling the tumor microenvironment through same-section fully automated spatial multiomics

Immune Landscape of Adenoid Cystic Carcinoma using Multiplex Immunofluorescence and Digital Pathology

Immune Landscape of Adenoid Cystic Carcinoma using Multiplex Immunofluorescence and Digital Pathology

Development and optimization of a broad hyperplex immunofuorescence assay for tumor immune microenvironment characterization

Development and optimization of a broad hyperplex immunofuorescence assay for tumor immune microenvironment characterization

Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by IL-6 blockade